BAY 869766(923032-38-6)
- Name: BAY 869766
- Synonyms:Refametinib (R enantiomer);Refametinib;Refametinib R enantiomer;
- Molecular Formula:C19H20F3IN2O5S
- Molecular Weight:572.344
- CAS Registry Number:923032-38-6
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.923032-38-6 BAY 869766
Assay:99% Transportation:By sea Application:Pharmaceutical industry
Min. Order:0
Supplier:Antimex Chemical Limied [
China (Mainland)] CAS No.923032-38-6 BAY 869766
Assay:99% Package:box or opp package Storage:cool drum Transportation:air or sea Application:BAY 869766
Min. Order:1Milligram
Supplier:weifang yangxu group co.,ltd [
China (Mainland)] CAS No.923032-38-6 BAY 869766
Assay:99% Appearance:white powder Package:drum or based on customers' requirement Storage:normal temperature storage Transportation:by sea, by air Application:We have different specifications for different applications
Min. Order:1Metric Ton
Supplier:Bluecrystal chem-union [
China (Mainland)] CAS No.923032-38-6 Refametinib (R enantiomer);923032-38-6
Assay:97% Appearance:Powder or liquid Package:According to customer Storage:Store in a tightly closed container, in a cool and dry place. Transportation:Fedex,DHL,TNT,BY SEA and BY AIR Application:Medicinal ChemistryBiomedicinePharmaceutical intermediatesChemistry experimentBiological experimentsChemical reagentFor R&D use only.
Min. Order:10Metric Ton
Supplier:Amadis Chemical Co., Ltd. [
China (Mainland)] CAS No.923032-38-6 Refametinib R enantiomer
Assay:>98% Package:inquiry Transportation:inquiry Application:Refametinib R enantiomer is a potent, selective and allosteric inhibitor of MEK1/2 in enzyme inhibition assays. It has been reported to inhibit MEK activity and inhibit anchorage-dependent growth....
Min. Order:0
Supplier:BOC Sciences [
United States]
Other Product
- 905966-60-1/1H-Pyrrole-1-acetamide, N-(aminoiminomethyl)-2,5-diphenyl-
- 905970-15-2/1H-Pyrrole-1-acetamide, 2-(2-chlorophenyl)-N-[[(3-hydroxypropyl)amino]iminomethyl]-5-(4-propoxyphenyl)-
- 905838-55-3/3-Thiopheneacetamide, 4-(2-chlorophenyl)-N-[[(3-hydroxypropyl)amino]iminomethyl]-2-(4-propoxyphenyl)-
- 906072-41-1/[1,1':3',1''-Terphenyl]-2'-acetamide, N-(aminoiminomethyl)-4-phenoxy- (9CI)
- 951328-78-2/3-Azabicyclo[3.1.0]hexane-2-carboxamide, N-[[[[4-(acetylamino)-3,5-dichlorophenyl]methyl]amino]iminomethyl]-3-phenyl-
- 900494-62-4/Imidazo[1,5-a]pyrimidin-6-amine, 2,3,4,8-tetrahydro-8,8-diphenyl-
- 918541-86-3/4H-Imidazol-4-one, 2-amino-5-[4-fluoro-3-(2-fluoro-3-pyridinyl)phenyl]-3,5-dihydro-3-methyl-5-(4-pyridinyl)-, (5S)-
- 942505-60-4/4(3H)-Pyrimidinone, 2-amino-5,6-dihydro-6-[3'-methoxy-5'-[(methylsulfonyl)oxy][1,1'-biphenyl]-3-yl]-3,6-dimethyl-
- 916770-80-4/3,5,13-Triazatetracyclo[15.3.1.12,5.17,11]tricosa-1(21),3,7,9,11(22),17,19-heptaene-12,23-dione, 4-amino-2-methyl-
- 892873-11-9/2,3-Pyridinediamine, N3-[[5-(1H-indol-6-yl)-2-(phenylmethoxy)phenyl]methyl]-
- 937369-38-5/11-Oxa-5,6-dithia-2,9-diazatridecanoic acid, 12,12-dimethyl-10-oxo-3,8-bis(3-thiazolidinylcarbonyl)-, 1,1-dimethylethyl ester, (3R,8R)-
- 937369-39-6/2-Pyrimidinamine, 4-[2-[3-(2-furanyl)phenyl]ethyl]-6-(3-methylbutoxy)-, 2,2,2-trifluoroacetate (1:1)
- 937370-61-1/1-Isoquinolinamine, 3,4-dihydro-3-(3'-methoxy[1,1'-biphenyl]-3-yl)-
- 937370-62-2/1-Isoquinolinamine, 3,4-dihydro-3-(3'-methoxy[1,1'-biphenyl]-3-yl)-, 2,2,2-trifluoroacetate (1:1)
- 936915-58-1/ONO 12380
- 817204-33-4/2'-deoxy-2'-fluoro-2'-C-methylcytidine
- 908112-43-6/4-(6,6-dimethyl-4-oxo-3-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-indazol-1-yl)-2-((1r,4r)-4-hydroxycyclohexylamino)benzamide
- 923032-38-6/BAY 869766
- 312904-62-4/1(2H)-Pyrazineacetamide, 6-chloro-3-[[2,2-difluoro-2-(2-pyridinyl)ethyl]amino]-N-[(3-fluoro-2-pyridinyl)methyl]-2-oxo-
- 936487-67-1/L-Serine, N2-[1,4-dioxo-4-[[4-(4-oxo-8-phenyl-4H-1-benzopyran-2-yl)MorpholiniuM-4-yl]Methoxy]butyl]-L-arginylglycyl-L-a-aspartyl-, inner salt
- 685898-44-6/L-Phenylalanine, 4-[bis(2-chloroethyl)oxidoaMino]-, (Hydrochloride) (1:2)
- 394730-60-0/Boceprevir
- 940908-79-2/(2'R)- 2'-Deoxy-2'-fluoro-2'-methylcytidine 3',5'-bis(2-methylpropanoate)
- 847442-84-6/A-837093
- 927880-90-8/RAF265(CHIR-265)
- 475488-23-4/5-(3-Benzyloxyphenyl)-7-[trans-3-[(pyrrolidin-1-yl)methyl]cyclobutyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine
- 586353-99-3/Pyrazolo[3,4-e]indazole-3-carboxamide, 1-[4-(aminosulfonyl)phenyl]-1,6-dihydro-
- 1035964-63-6/2(1H)-Pyridinone, 4-[[(2S)-2-hydroxy-2-phenylethyl]amino]-3-[7-methyl-5-(4-morpholinyl)-1H-benzimidazol-2-yl]-, hydrochloride (1:1)
- 536748-46-6/Eribaxaban
- 313489-71-3/LY 517717